D.T. PACE Versus High Dose Melphalan and Autologous Transplant in Patients With Previously Treated Multiple Myeloma
Status:
Completed
Trial end date:
2007-11-01
Target enrollment:
Participant gender:
Summary
This study has been designed to evaluate whether combination chemotherapy and
"anti-angiogenesis" therapy with thalidomide is equal or superior to autologous
transplantation for the treatment of multiple myeloma.